NUVASIVE INC·4

Sep 5, 5:04 PM ET

Raimundo Amy Belt 4

4 · NUVASIVE INC · Filed Sep 5, 2023

Insider Transaction Report

Form 4
Period: 2023-09-01
Transactions
  • Disposition to Issuer

    Restricted Stock Uni

    2023-09-014,8160 total
    Common Stock (4,816 underlying)
  • Disposition to Issuer

    Restricted Stock Uni

    2023-09-012,4270 total
    Common Stock (2,427 underlying)
  • Disposition to Issuer

    Restricted Stock Uni

    2023-09-013,7880 total
    Common Stock (3,788 underlying)
Footnotes (2)
  • [F1]Represented a contingent right to receive one share of the Issuer's common stock upon vesting.
  • [F2]Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the "Merger Agreement"), by and among the Issuer, Globus Medical, Inc. ("Globus") and Zebra Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Globus, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of Issuer common stock underlying such award.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION